Treatment with aripiprazole once-monthly injectable formulation is effective in improving symptoms and global functioning in schizophrenia with and without comorbid substance use – a post hoc analysis of the reliam study

HIGHLIGHTS

• who: Howard C. Margolese from the patients treated with AOM for , months in Canada have published the Article: Treatment with aripiprazole once-monthly injectable formulation is effective in improving symptoms and global functioning in schizophrenia with and without comorbid substance use - a post hoc analysis of the ReLiAM study, in the Journal: (JOURNAL)
• what: The aim of this post hoc analysis of the ReLiAM study is to investigate the treatment effects of reallife of AOM over a 1-year period in the subgroup of patients with reported compared with patients without Results: The aim of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.